Emergency Med

Your Article Summary

See Latest Articles

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting
Clinical Drug Investigation, 10/15/09

Guidotti M et al. – This review focuses on frovatriptan and highlights parameters that affect oral triptan choice, discusses the results of several open–label clinical and post–marketing surveillance studies of frovatriptan, and compares these naturalistic data with those from similar studies of other oral triptans. Efficacy data obtained from these trials are used to compare costs of treating migraine with frovatriptan and other oral triptans in four European countries...The low rate of headache recurrence with frovatriptan compared with other oral triptans, and the associated lower treatment costs, deserve consideration when choosing an oral triptan for the treatment of patients with acute migraine.

Today in Neurology/Neurosurgery...keeping you current

Receive free subspecialty "5-minute updates" via email

Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09

Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09

Stroke treatment with alteplase given 3·0—4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
The Lancet Neurology, 11/17/09

See All of Neurology/Neurosurgery

Today in Pain Management...keeping you current

Receive free subspecialty "5-minute updates" via email

Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09

Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09

Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/19/09

See All of Pain Management